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*e recurrent 16p11.2 microdeletion is characterized by developmental delays and a wide spectrum of congenital anomalies. It has
been well reported that individuals with this ∼593-kb interstitial deletion have an increased susceptibility toward the autism
spectrum disorder (ASD). Abnormalities of the eye and ocular adnexa are also commonly associated findings seen in individuals
with the 16p11.2 microdeletion syndrome, although these ophthalmic manifestations have not been well characterized. We
conducted an extensive literature review to highlight the eye features in patients with the 16p11.2 microdeletion syndrome and
describe a 5-year-old boy with the syndrome. *e boy initially presented with intellectual disability, speech delay, and defiant
behavior; diagnoses of attention deficit hyperactivity disorder (ADHD) and oppositional defiant disorder (ODD) were established.
He had a Chiari malformation type 1. His ophthalmic features included strabismus, hyperopia, and ptosis, and a posterior
embryotoxon was present bilaterally. From a systematic review of prior reported cases, the most common eye and ocular adnexa
findings observed were downslanting palpebral fissures, deep-set eyes, ptosis, and hypertelorism.
1. Introduction
*e 16p11.2 microdeletion syndrome (OMIM # 611913) is a
rare congenital condition with an estimated frequency of 3 in
10,000 in the general Icelandic public [1]. *e microdeletion
is also present in 1 in 100 persons with autism and 1 in 1,000
persons with a language or psychiatric disorder, most no-
tably speech delay and schizophrenia [1–3]. *e syndrome
most classically involves a heterozygous microdeletion of
about 593-kb from band 16p11.2, which is localized to the
short arm (p) of chromosome 16 [4]. A majority of cases
reported are de novo, but the deletion is inherited in an
autosomal dominant fashion from a parent 20% of the time
[4]. An equal sex ratio has been reported [4]. *e 16p11.2
microdeletion syndrome is characterized by the presence of
developmental delays related to expressive language skills,
autism spectrum disorder (ASD), diminished cognitive
function, macrocephaly, hypotonia, Chiari malformation,
learning disabilities, and high risk of encopresis and obesity
[3, 4]. Seizures are reported in approximately 20% of in-
dividuals affected [4]. Reported cases of 16p11.2 micro-
deletion have included variable ocular findings [5–25]. We
conducted an extensive literature review to summarize the
eye features in patients with the microdeletion syndrome
reported, to date, and describe a new case of a 5-year-old boy
with the 16p11.2 microdeletion syndrome.
2. Case Report
Our patient, now a 5-year-old boy, was born at 36 5/7 weeks
via vaginal delivery as the second child to a mother with a
pregnancy complicated by subchorionic hematoma and
bleeding at 17 weeks; birth weight was 6 lbs 13 oz. Tobacco
use (1/2 pack per day) was present for the first 3 months of
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pregnancy. Paternal family history was notable for the
presence of multiple personality disorder, depression, and
schizophrenia.
Additional medical problems of the patient included
significant speech and language delay, hypotonia with gait
abnormality, encopresis, incontinence, hyperphagia with
elevated BMI (85th percentile), attention deficit hyperac-
tivity disorder (ADHD), oppositional defiant disorder
(ODD), and Chiari malformation type 1.
Chromosomal microarray revealed a pathogenic
microdeletion at 16p11.2(29567295_30177999)x1 (Figure 1).
Parental testing revealed the mother was negative for the
16p11.2 microdeletion. *e father was deceased and thus
was not available for genetic testing.
At his most recent exam at 5 years and 3 months of age,
ocular abnormalities included strabismus (intermittent
exodeviation), bilateral mild hyperopia, ptosis of the left
eyelid, and posterior embryotoxon present bilaterally
(Figure 2).
3. Methods
We performed a systematic review of the literature to
summarize the reported ocular and ophthalmic features in
individuals with confirmed 16p11.2 microdeletions. A
PubMed search of “16p11.2 Microdeletion Syndrome” led to
a total of 44 articles; these articles, along with their refer-
ences, were reviewed in search of ocular findings.
(a)
Partial ideogram for chromosome 16 (gray bands) showing nucleotide location (GRCh37)
(b)
Figure 1: Deletion of 16p11.2 noted using microarray technology. (a) An ideogram of chromosome 16 shows the location of the deletion
that is present in this patient in the context of the entire chromosome 16 (arrows). (b) *e area highlighted (lighter colored region) in
portion (a) of this figure is shown in an expanded view in this image. *e deletion in this patient (highlighted by the red arrow; top row) is
shown via smooth signal and allele difference patterns, as well as copy number state values. *is deletion is localized to band 16p11.2
(nucleotides 29567295_30177999) [GRCh37].
(a) (b)
Figure 2: External photograph of the (a) right and (b) left eye showing the posterior embryotoxon (arrows).
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Additionally, all 27 references used for the OMIM 16p11.2
microdeletion syndrome entry (MIM # 611913) were
reviewed, along with their references. *ere were reports on
an estimated 140 patients with the 16p11.2 microdeletion
syndrome; 42 patient reports included descriptions of as-
sociated eye features (Table 1). *e LeBlanc and Nelson
study with 19 genetically confirmed 16p11.2 microdeletion
patients was excluded from this analysis due to a lack of eye
and ocular adnexa descriptions for their probands [25].
After including our patient, we calculated the frequency and
prevalence of each ocular finding from the total number of
cases with a confirmed deletion and reported eye findings
(Table 2). No articles were excluded based on year published,
and one article was excluded based on language.
Table 1: Ocular findings by patient.
Patient Year Reference Ophthalmic findings
1 2019 Stingl et al. (thisreport)
Intermittent exodeviation, mild hyperopia bilaterally, ptosis of the left eyelid, and a posterior
embryotoxon bilaterally
2 2018 Dell’Edera et al. [8] Hypertelorism (interpupillary distance of 2.9 cm), mildly downslanting palpebral fissures
3 2018 Gatti et al. [22] Downslanting palpebral fissures, slight eversion of the lateral third of the lower eyelid, longeyelashes
4 2015 Moreno-Igoa et al.[13]
Short and upslanting palpebral fissures, hypertelorism, epicanthal folds, ptosis of the eyelids, iris
heterochromia
5 2014 D’Angelo et al. [7] Deep-set eyes
6 2014 Pebrel-Richard et al.[14] Acute visual impairment appeared with retinitis pigmentosa and progressive visual loss
7 2014 Gerundino et al. [21] Downslanting palpebral fissures with deep-set eyes
8 2012 Kino et al. [11] Hypertelorism
9 2012 Tabet et al. [18] Deep-set eyes, thick supraorbital ridge
10
2011 Barge-schaapveld etal. [6]
Patient 1: sagging lateral upper eyelids
11 Patient 4: Full lateral part of the upper eyelids
12 Patient 3: right-sided convergent strabismus, hypotelorism, narrow palpebral fissures, full lateralpart of the upper eyelids, relatively thin eyebrows with lateral notches
13 2011 Schaaf et al. [15] Prominent eyes14 Mild horizontal nystagmus on extreme lateral gaze
15 2010 Bardakjian et al. [5] Left microphthalmia, persistent hyperplastic primary vitreous and posterior coloboma, rightposterior pole coloboma
16
2010 Shinawi et al. [9]
Mild hypertelorism
17 Downslanting palpebral fissures
18 Deep-set eyes
19 Hypertelorism
20 “Almond shaped” eyes
21 Hypertelorism
22
2010 Fernandez et al. [17]
Proband 2, 13yo boy: long, narrow palpebral fissures
23 proband3c (mother): deep-set eyes
24 Proband 3, 5 yo male: hypertelorism (inner canthal distance 3.4 cm, > +2SD)
25 2010 Sampson et al. [20] Retinal dystrophy, retinitis pigmentosa
26 2009 Shimojima et al. [16] Bilateral ptosis
27 2009 Hemple et al. [23] Deep-set eyes
28
2009 Bijlsma et al. [24]
Short palpebral fissures
29 Short and down-slanted palpebral fissures
30 Hypertelorism, bilateral epicanthic folds, short palpebral fissures, mild ptosis
31 Prominent infraorbital skin creases
32 Slightly deep-set eyes
33 Mild ptosis
34 Blepharophimosis, ptosis, epicanthus inversus, telecanthus
35 Downslanting and narrow palpebral fissures
36 Downslanting and narrow palpebral fissures
37 2008 Kumar et al. [12] Downslanting palpebral fissures
38
2007 Ballif et al. [19]
Downslanting palpebral fissures; bilateral epicanthal folds; deep-set eyes; absent tear ducts;
strabismus
39 Short and downslanting palpebral fissures; relative hypotelorism (3rd–10th percentile)
40 Downslanting palpebral fissures; left epicanthal fold; hypotelorism
41 Downslanting palpebral fissures; mild epicanthal folds; deep-set eyes
42 Narrow and slightly short palpebral fissures; relative hypertelorism (0 to +1SD); ptosis (right eye);strabismus (left eye); hyperopia
43 2002 Hernando et al. [10] Blepharophimosis, coloboma and unilateral chorioretinitis (right eye)
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4. Discussion
A systematic literature review revealed a total of 42 patients
with confirmed 16p11.2 microdeletion and reported oph-
thalmic findings (Table 1) [5–25]. After including our pa-
tient, we calculated the frequency and prevalence of each
ocular finding out the 43 patients with a confirmed deletion
and reported eye findings (Table 2).
*e 16p11.2 microdeletion syndrome was first re-
ported in association with multiple congenital anomalies
in 2002 in a boy who died at 5 months of age due to cardiac
failure. *e ocular findings of blepharophimosis, colo-
boma, and unilateral chorioretinitis were all reported in
this initial case [10]. In 2007, data regarding facial dys-
morphism in 16p11.2 microdeletion syndrome were
published by Ballif et al. *e dysmorphic features of 5
patients with confirmed microdeletions of 16p11.2 in-
cluded the ocular findings of palpebral fissures, epicanthal
folds, deep-set eyes, absent tear ducts, strabismus, hypo-
and hypertelorism, and hyperopia [19]. In 2008, addi-
tional information regarding facial dysmorphism in a boy
with 16p11.2 microdeletion was published by Kumar et al.
*is report consisted of downslanting palpebral fissures,
prominent ears, and broad nasal root [12]. In 2009,
Shimojima et al. reported the case of a 3-year-old boy with
a confirmed 16p11.2 microdeletion. *is boy was de-
scribed with mildly dysmorphic features, bilateral ptosis,
developmental delay, speech delay, hemivertebrae, early
onset obesity, and dilation of the lateral ventricles on
brain MRI [16]. Since then, there have been reports on
over 130 patients with documented 16p11.2 micro-
deletions; the majority of these reports lack ophthalmic
descriptions. It is possible these patients without reported
eye manifestations did not have abnormal eye or ocular
adnexa features, although we suspect the omission of
reported eye features was more frequently related to the
particular concentration of topics within each individual
report. For example, an article titled “*e copy number
variation landscape of congenital anomalies of the kidney
and urinary tract” by Miguel Verbitsky et al. describes
extrarenal malformations in a variety of patients with
copy number variants (CNV), including 9 patients with
confirmed 16p11.2 microdeletions; ophthalmic manifes-
tations were not featured [26].
Of the reports that included ophthalmic descriptions,
the most common eye feature reported was abnormal
palpebral fissures (n � 18, freq � 41.9%). Downslanting
was the most common description of palpebral fissures
(n � 12, freq � 66.7%), along with short (n � 6,
freq � 33.3%) and narrow (n � 5, freq � 27.8%). Less
commonly, there was one report of upslanting (n � 1,
freq � 5.6%) and one report of long (n � 1, freq � 5.6%)
palpebral fissures. *e next most common ocular find-
ings following abnormal palpebral fissures was deep-set
eyes (n � 9, freq � 20.9%). *is was followed by both
ptosis and hypertelorism (n � 8, freq � 18.6%) (Table 2).
Epicanthal folds and strabismus (n � 4, freq � 9.3%) were
also common ocular findings. Infrequent reportings were
notable for retinitis pigmentosa, coloboma, blephar-
ophimosis, hypotelorism, hyperopia, and full lateral part
of the upper eyelids (n � 2, freq � 4.7%). Isolated oph-
thalmic features included iris heterochromia, thick su-
praorbital ridge, microphthalmia, chorioretinitis,
prominent eyes, horizontal nystagmus, retinal dystro-
phy, absent tear ducts, eyelid eversion, long eyelashes,
sagging lateral upper eyelids, prominent infraorbital
creases, epicanthus inversus, and telecanthus (n � 1,
freq � 2.3%).
In summary, this report and literature review of the
16p11.2 microdeletion syndrome contributes to our
understanding of the relationship of the 16p11.2
microdeletion and ocular abnormalities and provides
incentive to further investigate the phenotype. A limi-
tation of our study was the inability to directly compare
the frequency of these ocular findings to their incidence
in the general public. Further studies with a larger sample
size could be beneficial to distinguish whether many of
these features are indeed a true correlation with this
microdeletion syndrome. We also recommend further
investigation on the role of 16p11.2 microdeletion in eye
development to help elucidate the mechanisms under-
lying ophthalmologic and adnexa abnormalities seen in
the syndrome.
Table 2: Frequency of ocular findings.
Ocular findings Number (n) Frequency (%)






Deep-set eyes 9 20.9
Ptosis 8 18.6
Hypertelorism 8 18.6
Epicanthal folds 4 9.3
Strabismus 4 9.3





Full lateral part of the upper eyelids 2 4.7
Iris heterochromia 1 2.3
*ick supraorbital ridge 1 2.3
Microphthalmia 1 2.3
Chorioretinitis 1 2.3
Prominent eyes 1 2.3
Horizontal nystagmus 1 2.3
Retinal dystrophy 1 2.3
Absent tear ducts 1 2.3
Eyelid eversion 1 2.3
Long eyelashes 1 2.3
Sagging lateral upper eyelids 1 2.3
Prominent infraorbital skin creases 1 2.3
Epicanthus inversus 1 2.3
Telecanthus 1 2.3
Posterior embryotoxon 1 2.3
∗Frequency within the subset of patients presenting with abnormal pal-
pebral fissures.
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